Latest: FDA Approves New Biosimilar for Oncology Treatment

Preclinical Study Reveals Potential of Multireceptor Antagonist to Block CGRP and PACAP

by Neurology Live

14 September, 2025

0 Mins

In a recent study, investigators developed multireceptor antagonist peptides that could block CGRP and PACAP, providing proof-of-concept for a potential new approach to targeting pathways involved in migraine.

Tags:

Author

Neurology Live

Navigating Alzheimer’s Care in Illinois: Resources Every Family Needs to Know

Australian couple-based genetic screening program feasible and accepted

📢

300x250 Banner

Preclinical Study Reveals Potential of Multireceptor Antagonist to Block CGRP and PACAP

Tags:

Neurology Live

Navigating Alzheimer’s Care in Illinois: Resources Every Family Needs to Know

Australian couple-based genetic screening program feasible and accepted

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition